Human Genetics

, Volume 92, Issue 3, pp 289–295

Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis

  • Hagit Sereth
  • Tzipora Shoshani
  • Nurit Bashan
  • Bat-sheva Kerem
Original Investigations


The major cystic fibrosis (CF) mutation, ΔF508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-ΔF chromosomes. Its frequency among non-ΔF508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific “background” as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200kb 5′ to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-ΔF508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (ΔF508, W1282X, G542X, N1303K, 3849+10 kb C→T, Q359K/T360K, S549I, S549R, and 1717-1G→A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (ΔF508, W1282X, G542X, N1303K, Q359K/ T360K, S549R, and 1717-1G→A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G→A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. MacGraw-Hill, New York, pp 2649–2680Google Scholar
  2. Chehab FF, Johnson J, Louie E, Goossens M, Kawasaki E, Erlich H (1991) A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the ΔF508 mutation: implications for prenatal diagnosis and mutation origin. Am J Hum Genet 48:223–226Google Scholar
  3. Dean M, Drumm ML, Stewart C, Gerrard B, Perry A, Hidaka N, Cole JL, Collins FS, Iannuzzi MC (1990) Approaches to localizing disease genes as applied to cystic fibrosis. Nucleic Acids Res 18:345–350Google Scholar
  4. Dork T, Neumann T, Wulbrand U, Wulf B, Kalin N, Maas G, Krawczak M, Guillermit H, Ferec C, Horn G, Klinger K, Kerem B, Zielenski J, Tsui L-C, Tummler B (1992) Intraand extragenic haplotypes of CFTR mutations in cystic fibrosis families. Hum Genet 88:417–425Google Scholar
  5. Estivill X, Farrall M, Scambler PJ, Bell GM, Hawley KMF, Lench NJ, Bates GP, Kruyer HC, Frederick PA, Stanier P, Watson EK, Williamson R, Wainwright BJ (1987a) A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands. Nature 326:840–845Google Scholar
  6. Estivill X, Scambler PJ, Wainwright BJ, Hawley K, Frederick P, Schwanz M, Baiget M, Kere J, Williamson R, Farrall M (1987b) Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics 1:257–263Google Scholar
  7. European Working group on CF Genetics (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 85:436–445Google Scholar
  8. Ferec C, Audrezet MP, Mercier B, Guillermit H, Moullier P, Quere I, Verlingue C (1992) Detection of over 98% cystic fibrosis mutations in a Celtic population. Nature Genet 1:188–191Google Scholar
  9. Gasparini P, Dognini M, Bonizzato A, Pignatti PF, Morral N, Estivill X (1991a) A tetranucleotide repeat polymorphism in the cystic fibrosis gene. Hum Genet 86:625Google Scholar
  10. Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, Bonizzato A, Chillon M, Sangiuolo F, Novelli G, Dallapiccola B, Pignatti PF, Estivill X (1991b) The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics 10:193–200Google Scholar
  11. Iannuzzi MC, Dean M, Drumm ML, Hidaka N, Cole JL, Perry A, Stewart C, Gerrard B, Collins FS (1989) Isolation of additional polymorphic clones from the cystic fibrosis region, using chromosome jumping from D7S8. Am J Hum Genet 44:695–703Google Scholar
  12. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080Google Scholar
  13. Kerem B, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan JR, Collins FS, Rommens JM, Tsui L-C (1990) Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 87:8447–8451Google Scholar
  14. Kunkel TA (1985) The mutational specificity of DNA polymerase b during in vitro DNA synthesis. J Biol Chem 260:5787–5796Google Scholar
  15. Osborne L, Knight R, Santis G, Hodson M (1991) A mutation in the second nucleotide binding fold of the cystic fibrosis gene. Am J Hum Genet 48:608–612Google Scholar
  16. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073PubMedGoogle Scholar
  17. Romeo G, Galietta JLV, Devoto M (1989) Why is the CF gene frequent? Hum Genet 84:1–5Google Scholar
  18. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui L-C, Collins FS (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065Google Scholar
  19. Rommens JM, Kerem B, Greer W, Chang P, Tsui L-C, Ray P (1990) Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 46:395–396Google Scholar
  20. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplification of beta globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354PubMedGoogle Scholar
  21. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491PubMedGoogle Scholar
  22. Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Sereth H, Yaar L, Kerem E, Kerem B (1992a) Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 50:222–228Google Scholar
  23. Shoshani T, Berkun Y, Yahav Y, Augarten A, Bashan N, Rivlin Y, Gazit E, Sereth H, Kerem E, Kerem B (1992b) A new mutation in the cystic fibrosis gene, comprised of two adjacent DNA alterations, is common among Georgian Jews. Genomics 15:236–237Google Scholar
  24. Tsui LC (1992) Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the cystic fibrosis genetic analysis consortium. Hum Mutat 1: 197–203Google Scholar
  25. Tsui L-C, Buchwald M, Barker D, Braman JC, Knowlton R, Schumn JW, Eiberg H, Mohr J, Kennedy D, Plavsic N, Zsiga M, Markiewicz D, Akots G, Brown V, Helms C, Gravius T, Parker C, Rediker K, Donis-Keller H (1985) Cystic fibrosis locus defined by a genetically linked polymorphism DNA marker. Science 230:1045–1057Google Scholar
  26. Vidaud M, Fanen P, Martin J, Ghanem N, Nicolas S, Goossens M (1990) Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet 85:446–449Google Scholar
  27. Wagner DK, Cavalli-Sforza LL (1975) Ethnic variation in genetic disease: possible roles of hitchhiking and epistasis. Am J Hum Genet 27:348–364Google Scholar
  28. Zielenski J, Rozmahel R, Bozon D, Kerem B, Grzelczak Z, Riordan JR, Rommens JM, Tsui L-C (1991) Genomic DNA sequences of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10:214–228Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Hagit Sereth
    • 1
  • Tzipora Shoshani
    • 1
  • Nurit Bashan
    • 1
  • Bat-sheva Kerem
    • 1
  1. 1.Genetics DepartmentLife Sciences Institute, The Hebrew University of JerusalemJerusalemIsrael

Personalised recommendations